GemCap Biotech ApS: Financial statements 2019
CVR: 38189174
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
GemCap Biotech ApS (CVR 38189174) has filed annual accounts for 2019. In 2019, the company reported a net result of EUR 0 compared with EUR 0 the year before. Equity in the 2019 report amounted to EUR 6,750. The solvency ratio was 100%.
- Profit/Loss
- EUR 0
- Equity
- EUR 6,750
- Total Assets
- EUR 6,750
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | - | 0 EUR | 7 t. EUR | - |
| 2018 | - | - | 0 EUR | 7 t. EUR | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
GemCap Biotech ApS has published its annual report for 2018. The net result was DKK 0.
About GemCap Biotech ApS
GemCap Biotech ApS was a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2016. The company has been dissolved on 24 March 2024. The company was registered under the industry Anden finansiel formidling undtagen forsikring og pensionsforsikring, i.a.n.. According to the 2023 annual report, the company had an average of 0 employees. In 2023, the company reported a net result of EUR 0 compared with EUR 0 the year before. Equity in the 2023 report amounted to EUR 27,000.